14 September 2026
Dr Thembisile Xulu is the new health Director-General, inheriting a strained department, healthcare-worker shortages and NHI litigation.
9 September 2026
Aspen has abandoned local lenacapavir production, citing no guaranteed demand, and is backing Merck's alimatravir pill instead.
10 June 2026
The lenacapavir HIV Prevention Injection rollout begins in SA, but activists warn that limited supply from Gilead could blunt the impact.
29 April 2026
South Africa must navigate the upcoming end of Global Fund HIV funding by 2034. Learn more about the implications.
26 March 2026
Lenacapavir manufacturing in SA aims to strengthen supply chains and provide critical HIV prevention solutions.
6 November 2025
South Africa's TB crisis reveals a grave situation: one in five diagnosed individuals succumb to tuberculosis each year.
6 November 2025
Understand the impact of stockouts on the South Africa TB epidemic and SANAC's strategies for effective solutions.
12 July 2024
Sanac aims to test and treat 95% of HIV-infected children, addressing rising infection rates among infants, especially in Tshwane.